Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia
- PMID: 10073989
- DOI: 10.1161/01.atv.19.3.802
Characterization of a new form of inherited hypercholesterolemia: familial recessive hypercholesterolemia
Abstract
We previously described a Sardinian family in which the probands had a severe form of hypercholesterolemia, suggestive of familial hypercholesterolemia (FH). However, low density lipoprotein (LDL) receptor activity in fibroblasts from these subjects and LDL binding ability were normal. The characteristics of the pedigree were consistent with an autosomal recessive trait. Sitosterolemia and pseudohomozygous hyperlipidemia were ruled out. A second Sardinian kindred with similar characteristics was identified. Probands showed severe hypercholesterolemia, whereas their parents and grandparents were normolipidemic. FH, familial defective apoprotein (apo) B, sitosterolemia, and cholesteryl ester storage disease were excluded by in vitro studies. We addressed the metabolic basis of this inherited disorder by studying the in vivo metabolism of LDL in 3 probands from these 2 families. 125I-LDL turnover studies disclosed a marked reduction in the fractional catabolic rate (0.19+/-0.01 versus 0.36+/-0.03 pools per day, respectively; P<0.001) and a significant increase in the production rate [20.7+/-4.4 versus 14. 0+/-2.4 mg. kg-1. d-1, respectively; P<0.01] of LDL apoB in the probands compared with normolipidemic controls. We then studied the in vivo biodistribution and tissue uptake of 99mtechnetium-labeled LDL in the probands and compared them with those in normal controls and 1 FH homozygote. The probands showed a significant reduction in hepatic LDL uptake, similar to that observed in the FH homozygote. A reduced uptake of LDL by the kidney and spleen was also observed in all patients. Our findings suggest that this recessive form of hypercholesterolemia is due to a marked reduction of in vivo LDL catabolism. This appears to be caused by a selective reduction in hepatic LDL uptake. We propose that in this new lipid disorder, a recessive defect causes a selective impairment of LDL receptor function in the liver.
Similar articles
-
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):560-5. doi: 10.1161/01.ATV.0000155323.18856.a2. Epub 2005 Jan 6. Arterioscler Thromb Vasc Biol. 2005. PMID: 15637307
-
Coinheritance of two mild defects in low density lipoprotein receptor function produces severe hypercholesterolemia.J Clin Endocrinol Metab. 1991 Jan;72(1):179-87. doi: 10.1210/jcem-72-1-179. J Clin Endocrinol Metab. 1991. PMID: 1986017
-
ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.Arterioscler Thromb. 1994 Apr;14(4):501-10. doi: 10.1161/01.atv.14.4.501. Arterioscler Thromb. 1994. PMID: 8148348 Review.
-
Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia.J Clin Endocrinol Metab. 1998 Jun;83(6):2167-74. doi: 10.1210/jcem.83.6.4840. J Clin Endocrinol Metab. 1998. PMID: 9626156
-
Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism.Atheroscler Suppl. 2002 Mar;2(3):1-4. doi: 10.1016/s1567-5688(01)00012-5. Atheroscler Suppl. 2002. PMID: 11923121 Review.
Cited by
-
Deletion of LDLRAP1 Induces Atherosclerotic Plaque Formation, Insulin Resistance, and Dysregulated Insulin Response in Adipose Tissue.Am J Pathol. 2022 Jul;192(7):1092-1108. doi: 10.1016/j.ajpath.2022.03.014. Epub 2022 Apr 20. Am J Pathol. 2022. PMID: 35460615 Free PMC article.
-
Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC.J Mol Cell Cardiol. 2017 Apr;105:38-48. doi: 10.1016/j.yjmcc.2017.02.005. Epub 2017 Feb 28. J Mol Cell Cardiol. 2017. PMID: 28257760 Free PMC article.
-
Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI.Curr Opin Lipidol. 2009 Jun;20(3):236-41. doi: 10.1097/MOL.0b013e32832aee82. Curr Opin Lipidol. 2009. PMID: 19421056 Free PMC article. Review.
-
The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population.Sci Rep. 2017 Dec 6;7(1):17087. doi: 10.1038/s41598-017-17181-9. Sci Rep. 2017. PMID: 29213121 Free PMC article.
-
The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.Curr Atheroscler Rep. 2015 May;17(5):508. doi: 10.1007/s11883-015-0508-7. Curr Atheroscler Rep. 2015. PMID: 25782778 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous